SlideShare a Scribd company logo
1 of 12
Bryan Abadilla, SRT
ACC, ONT RT-13
EXACERBATION OF ASTHMA
• Definition:
– Asthma: Respiratory disease in which the airways become inflamed
causing narrowing and swelling. Also, more mucus is produced
which makes breathing more difficult.
– Exacerbation of asthma: An event during the natural course of
asthma in which the patients baseline dyspnea, cough, and or
sputum is beyond what is normal for the patient on a daily basis.
• Symptoms:
– SOB *
– Anxiety *
– Cough *
– Irregular respiratory patterns *
– Orthopnea
– Yellow or green sputum, hemoptysis
– Chest tightness *
Causes:
– Infection of tracheobronchial tree ( airway inflammation)
– Air pollution (airway inflammation)
– Exercise or stress
– Smoking of any kind
– 1/3 of severe exacerbations cannot be identified
• Diagnosis:
– 4 classes (mild, moderate, severe, life threatening)
– Pulse ox on room air, <92-94 one hour after standard tx =
hospitalization
• Treatment:
– O2 therapy; > 90% saturation
– SABA + Ipratropium by nebulizer/MDI Q20 mins (or continuous
neb)
• Albuterol
– Corticosteroid
• Pulmicort
• Symbicort
• Prognosis:
– Send pt home with systemic corticosteroids.
– Allergen avoidance
WHAT IS EXACERBATION OF ASTHMA?
Medscape.com, aafp.org
• 58Yr, African American Female arrives in ER via ambulance on NRB.
• Chief complaint:
– shortness of breath
• Diagnosis: Exacerbation of asthma
• Hx:
– Asthma
– 4 pack year smoking Hx (8 cigarettes a day X 10 yrs)
– CHF
– Multiple hospitalization for exacerbation of asthma
– Used to work at Home Depot for 5 years
– Currently unemployed
PATIENT DATA
• Shortness of breath; shallow
• Anxious
• Tachypnic and in severe respiratory distress
• Use of accessory muscles
• Breath sounds: Severe insp/exp wheezing
• Vitals:
– HR: 115, RR: 34, BP: 142/62, Temp: 37.9C, SpO2 90% NRB
• Placed Pt. on 50% venti mask
INITIAL ASSESSMENT
• ABG on 50% Venti mask. Uncompensated Respiratory Acidosis
with mild hypoxemia.
– pH 7.25
– PaCO2 65
– PaO2 65
– HCO3- 25
• Critical lab findings only
– Low Calcium: 1.9 mmol/L
– High glucose: 133 mg/dL
– High WBC: 13.5 (13,500/mcL)
LAB FINDINGS
• Doctor’s orders (pt in ER)
– 50% venture mask
– Titrate oxygen usage to a minimum
– ABG
– Labs (cbc, electorlytes, lipids)
– 5mg albuterol via aerogen (ultrasonic/mesh nebulizer)
• Administered x2, second dose: 5mg albuterol via aerogen 20 mins after, third dose: 2.5mg albuterol via aerogen 20 mins after second dose.
– Racemic Epinephrine 2.25mg via HHN
– Ativan via IV 2mg.
• Allergies?
• Assessment
– Pt still tachypnic and wheezing after first treatment. Slight tachycardia with HR: 100-105, RR: 30-32.
– 20 mins post second treatment, breath sounds improve, slight expiratory wheeze.
– Ativan administered by nurse, Racemic epinephrine administered via HHN
• During administration of Ativan and racemic epinephrine pt complains of itchy skin and itchy throat.
• Stopped racemic epinephrine treatment.
• Nurse administered Benadryl.
– Patient vitals stable, breath sounds still slight wheeze, pt request to rest. Placed on 4L NC w/ bubble humidifier. Monitor patient status.
DAY 1
• Doctor’s orders
– Oxygen therapy keep SpO2 >92%.
– Titrate oxygen usage to minimum
– Duoneb (albuterol 2.5mg/ipratropium bromide 0.5mg in 3ml solution) Q4 via UPA
– Pulmicort 0.5mg BID (1mg max per day)
• Assessment
– Vitals stable: HR: 90, RR 18, BS: slight wheeze bilaterally, BP: 132/70, Tem p 37C.
– No respiratory distress or SOB
– Speaking in full sentences with no signs of distress
– Semi-fowler, non-productive spontaneous cough, sputum: none. Skin is normal, warm, and dry.
– Pt tolerated tx well. Post BS: unchanged, slight wheeze bilaterally.
– Second Q4 tx post BS: improved, clear/diminished bilaterally.
– Decreased nasal cannula from 4L to 2L. Pt. SpO2 99% on 4L. Five minutes post oxygen decrease pt
SpO2 98%. Continue Q4 tx and monitor.
DAY 2
• Doctor’s orders
– Oxygen therapy. Keep SpO2 >92%
– Titrate oxygen usage to a minimum
– Titrate down to Room air.
– Duoneb (albuterol 2.5mg/ipratropium bromide 0.5mg in 3ml solution) Q4 via UPA
– Pulmicort 0.5mg BID (1mg max per day)
• Assessment
– Reduced oxygen from 2L NC to Room air. Pt SpO2 99% on 2L. Waited 5 minutes to check
Spo2 Via pulse ox. Room air SpO2 96%.
– Pt looks and sounds great. Speaking in full sentences, smiling and excited to go home.
– Vital signs stable – HR: 76, RR 18, BS: clear and diminished bilaterally, BP: 134/72, Temp:
37.1C
– Upon next Q4 tx discovered patient has been discharged and sent home.
DAY 3
Name Class Dosage Indication
Albuterol Bronchodilator 2.5mg in 3ml
solution (mixed
with NL saline)
Bronchospasms,
exacerbation of
asthma.
Duoneb Bronchodilator 2.5 mg
albuterol/0.5 mg
atrovent
Bronchospasms,
wheezing.
Racemic
Epinephrine
Vasopressor 2.25%/0.5 ml Chest tightness,
wheezing.
Pulmicort Corticosteroids 0.5 mg BID Maintenance Tx
of asthma.
Ativan Benzodiazapines 2mg via IV Anti-anxiety.
MEDICATION LIST
www.drugs.com
• Maintain SpO2 > 92%
• Achieve patent airway and maintain airway clearance
– Bronchodilator and oxygen therapy
• Recommend avoiding irritants such as pollen, air pollution, cigarette smoke or any
others that might trigger an asthma attack.
• Send patient home with peak flow
• Send patient home with prescriptions for bronchodilator therapy.
• Day 1 suggestions:
– Instead of trying three treatments of albuterol every 20 minutes, why not try a continuous neb
treatment? And monitor patient during treatment?
• Day 2&3 suggestions:
– After recording breath sounds as clear/diminished, change Q4 to Q6? Or change it to Q4PRN?
RECOMMENDATIONS AND PLAN OF CARE
• Patient arrives in ED via ambulance, 4 pack year smoking hx, and hx of CHF
– Respiratory distress
– Tachypnic
– Tachycardic
– Anxious
– Increased WOB
– SOB
– Severe insp/exp wheezing
– ABG results: Uncompensated Respiratory Acidosis with mild hypoxemia
• Day 1
– Placed on 50% venture mask, ABG, LABS, Albuterol, Racemic Epinephrine, and Ativan treatments.
– Pt. allergic reaction to Ativan (racemic epi?)
• Benadryl administered by RN
– Breath sounds improved to moderate wheezing from severe, monitor patient.
• Day 2/3
– Titrate oxygen use down, but keep SpO2 > 90%
– Pt. now on 4/2L NC SpO2 96-98%
– Duoneb and Pulmicort
– Vitals stable, BS improving to mild wheezing and clear/diminished.
• Sent patient home with bronchodilator treatments, and educated patient to prevent asthma attacks by avoiding irritants and other
triggers.
OVERALL SUMMARY AND CONCLUSION
• http://www.medscape.com/viewarticle/707497_2
• http://www.webmd.com/lung/10-signs-copd-exacerbation
• http://www.drugs.com
RESOURCES

More Related Content

What's hot

Mechanical ventilation of bronchial asthma, is it a real dilemma
Mechanical ventilation of bronchial asthma, is it a real dilemmaMechanical ventilation of bronchial asthma, is it a real dilemma
Mechanical ventilation of bronchial asthma, is it a real dilemmaMohammad Samak
 
Status asthmaticus ancy ppt
Status asthmaticus ancy pptStatus asthmaticus ancy ppt
Status asthmaticus ancy pptancy143
 
Icu management in obstructive airway disease
Icu management in obstructive airway diseaseIcu management in obstructive airway disease
Icu management in obstructive airway diseaseMuhammad Asim Rana
 
Case Presentation (Resp Distress C O P Datypical)
Case Presentation (Resp Distress C O P Datypical)Case Presentation (Resp Distress C O P Datypical)
Case Presentation (Resp Distress C O P Datypical)jben501
 
Mechanical Ventilation for severe Asthma
Mechanical Ventilation for severe AsthmaMechanical Ventilation for severe Asthma
Mechanical Ventilation for severe AsthmaDr.Mahmoud Abbas
 
Status asthmaticus by Pushpa Raj Sharma
Status asthmaticus by   Pushpa Raj SharmaStatus asthmaticus by   Pushpa Raj Sharma
Status asthmaticus by Pushpa Raj SharmaPushpa Sharma
 
Non-Invasive Ventilation
Non-Invasive VentilationNon-Invasive Ventilation
Non-Invasive VentilationSCGH ED CME
 
Weekly death round
Weekly death roundWeekly death round
Weekly death roundBeka Aberra
 
Final case pediatric mechanical ventilation
Final case pediatric mechanical ventilationFinal case pediatric mechanical ventilation
Final case pediatric mechanical ventilationAhmed AlGahtani, RRT
 
sepsis SSC 2021 Updates Ventilation and additional therapy
sepsis SSC 2021 Updates Ventilation and additional therapysepsis SSC 2021 Updates Ventilation and additional therapy
sepsis SSC 2021 Updates Ventilation and additional therapyMEEQAT HOSPITAL
 
Pediatric Asthma Exacerbation Management
Pediatric Asthma Exacerbation ManagementPediatric Asthma Exacerbation Management
Pediatric Asthma Exacerbation ManagementFatima Farid
 
Monsoon Illnesses affecting Lungs (Part 1 of 2)
Monsoon Illnesses affecting Lungs (Part 1 of 2)Monsoon Illnesses affecting Lungs (Part 1 of 2)
Monsoon Illnesses affecting Lungs (Part 1 of 2)Manjit Tendolkar
 
Pulmonary Board Review 2008
Pulmonary Board Review 2008Pulmonary Board Review 2008
Pulmonary Board Review 2008guest153ec3
 
Severe asthma management
Severe asthma managementSevere asthma management
Severe asthma managementSCGH ED CME
 

What's hot (20)

Mechanical ventilation of bronchial asthma, is it a real dilemma
Mechanical ventilation of bronchial asthma, is it a real dilemmaMechanical ventilation of bronchial asthma, is it a real dilemma
Mechanical ventilation of bronchial asthma, is it a real dilemma
 
Status asthmaticus ancy ppt
Status asthmaticus ancy pptStatus asthmaticus ancy ppt
Status asthmaticus ancy ppt
 
Icu management in obstructive airway disease
Icu management in obstructive airway diseaseIcu management in obstructive airway disease
Icu management in obstructive airway disease
 
Status asthmaticus
Status asthmaticusStatus asthmaticus
Status asthmaticus
 
Case Presentation (Resp Distress C O P Datypical)
Case Presentation (Resp Distress C O P Datypical)Case Presentation (Resp Distress C O P Datypical)
Case Presentation (Resp Distress C O P Datypical)
 
Respiratory failure
Respiratory failure Respiratory failure
Respiratory failure
 
Mechanical Ventilation for severe Asthma
Mechanical Ventilation for severe AsthmaMechanical Ventilation for severe Asthma
Mechanical Ventilation for severe Asthma
 
Status asthmaticus by Pushpa Raj Sharma
Status asthmaticus by   Pushpa Raj SharmaStatus asthmaticus by   Pushpa Raj Sharma
Status asthmaticus by Pushpa Raj Sharma
 
meningitis
meningitismeningitis
meningitis
 
Non-Invasive Ventilation
Non-Invasive VentilationNon-Invasive Ventilation
Non-Invasive Ventilation
 
Weekly death round
Weekly death roundWeekly death round
Weekly death round
 
Pulmonary functions Tests
Pulmonary functions TestsPulmonary functions Tests
Pulmonary functions Tests
 
Final case pediatric mechanical ventilation
Final case pediatric mechanical ventilationFinal case pediatric mechanical ventilation
Final case pediatric mechanical ventilation
 
Bronchospasm during induction
Bronchospasm during inductionBronchospasm during induction
Bronchospasm during induction
 
Status asthmaticus
Status asthmaticusStatus asthmaticus
Status asthmaticus
 
sepsis SSC 2021 Updates Ventilation and additional therapy
sepsis SSC 2021 Updates Ventilation and additional therapysepsis SSC 2021 Updates Ventilation and additional therapy
sepsis SSC 2021 Updates Ventilation and additional therapy
 
Pediatric Asthma Exacerbation Management
Pediatric Asthma Exacerbation ManagementPediatric Asthma Exacerbation Management
Pediatric Asthma Exacerbation Management
 
Monsoon Illnesses affecting Lungs (Part 1 of 2)
Monsoon Illnesses affecting Lungs (Part 1 of 2)Monsoon Illnesses affecting Lungs (Part 1 of 2)
Monsoon Illnesses affecting Lungs (Part 1 of 2)
 
Pulmonary Board Review 2008
Pulmonary Board Review 2008Pulmonary Board Review 2008
Pulmonary Board Review 2008
 
Severe asthma management
Severe asthma managementSevere asthma management
Severe asthma management
 

Viewers also liked

Bronchial Asthma in Acute Exacerbation, Diabetes Mellitus-Type II, Hyperchole...
Bronchial Asthma in Acute Exacerbation, Diabetes Mellitus-Type II, Hyperchole...Bronchial Asthma in Acute Exacerbation, Diabetes Mellitus-Type II, Hyperchole...
Bronchial Asthma in Acute Exacerbation, Diabetes Mellitus-Type II, Hyperchole...Jack Frost
 
Pneumothorax, and then, Pulmonary Edema
Pneumothorax, and then, Pulmonary EdemaPneumothorax, and then, Pulmonary Edema
Pneumothorax, and then, Pulmonary EdemaBryan Abadilla
 
Abadilla, Bryan Portfolio
Abadilla, Bryan PortfolioAbadilla, Bryan Portfolio
Abadilla, Bryan PortfolioBryan Abadilla
 
Management of asthma seminar
Management of asthma seminarManagement of asthma seminar
Management of asthma seminarKirie Kozanegawa
 
Asthma in the acute care setting
Asthma in the acute care settingAsthma in the acute care setting
Asthma in the acute care settingDr.Mahmoud Abbas
 
Asthma exacerbation case study in pediatrics
Asthma exacerbation case study in pediatricsAsthma exacerbation case study in pediatrics
Asthma exacerbation case study in pediatricsLyndon Woytuck
 
Azithromycin and asthma
Azithromycin and asthmaAzithromycin and asthma
Azithromycin and asthmacscoville
 
TEDx Manchester: AI & The Future of Work
TEDx Manchester: AI & The Future of WorkTEDx Manchester: AI & The Future of Work
TEDx Manchester: AI & The Future of WorkVolker Hirsch
 

Viewers also liked (9)

Bronchial Asthma in Acute Exacerbation, Diabetes Mellitus-Type II, Hyperchole...
Bronchial Asthma in Acute Exacerbation, Diabetes Mellitus-Type II, Hyperchole...Bronchial Asthma in Acute Exacerbation, Diabetes Mellitus-Type II, Hyperchole...
Bronchial Asthma in Acute Exacerbation, Diabetes Mellitus-Type II, Hyperchole...
 
Pneumothorax, and then, Pulmonary Edema
Pneumothorax, and then, Pulmonary EdemaPneumothorax, and then, Pulmonary Edema
Pneumothorax, and then, Pulmonary Edema
 
Abadilla, Bryan Portfolio
Abadilla, Bryan PortfolioAbadilla, Bryan Portfolio
Abadilla, Bryan Portfolio
 
Management of asthma seminar
Management of asthma seminarManagement of asthma seminar
Management of asthma seminar
 
Asthma in the acute care setting
Asthma in the acute care settingAsthma in the acute care setting
Asthma in the acute care setting
 
Asthma exacerbation case study in pediatrics
Asthma exacerbation case study in pediatricsAsthma exacerbation case study in pediatrics
Asthma exacerbation case study in pediatrics
 
Azithromycin and asthma
Azithromycin and asthmaAzithromycin and asthma
Azithromycin and asthma
 
Acute Severe Asthma
Acute Severe AsthmaAcute Severe Asthma
Acute Severe Asthma
 
TEDx Manchester: AI & The Future of Work
TEDx Manchester: AI & The Future of WorkTEDx Manchester: AI & The Future of Work
TEDx Manchester: AI & The Future of Work
 

Similar to Exacerbation of Asthma

Respiratory conditions in Critically ill Surgical patient
Respiratory conditions in Critically ill Surgical patientRespiratory conditions in Critically ill Surgical patient
Respiratory conditions in Critically ill Surgical patientMohamed Alasmar
 
Ventilation Strategy in obstructive Lung disease
Ventilation Strategy  in obstructive Lung diseaseVentilation Strategy  in obstructive Lung disease
Ventilation Strategy in obstructive Lung diseaseGOWTHAMAN Gowthaman.Tb
 
ARDS-acute respiratory distress syndrome
ARDS-acute respiratory distress syndromeARDS-acute respiratory distress syndrome
ARDS-acute respiratory distress syndromeMarkendeyKhanna
 
Chronic obstructive pulmonary disease
Chronic obstructive pulmonary diseaseChronic obstructive pulmonary disease
Chronic obstructive pulmonary diseaseHamsa Sam Sam
 
Oxygen toxicity and it’s mechanism
Oxygen toxicity and it’s mechanismOxygen toxicity and it’s mechanism
Oxygen toxicity and it’s mechanismrashree-singh
 
COPD with RV failure - Case Presentation
COPD with RV failure - Case PresentationCOPD with RV failure - Case Presentation
COPD with RV failure - Case PresentationFlemin Thomas
 
G M C F I N A L
G M C  F I N A LG M C  F I N A L
G M C F I N A Lgoolappa
 
ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASEACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASEDr Dravid m c
 
Approach patient with cough
Approach patient with cough Approach patient with cough
Approach patient with cough SoM
 
NIV in Acute Exacerbation of COPD
NIV in Acute Exacerbation of COPDNIV in Acute Exacerbation of COPD
NIV in Acute Exacerbation of COPDSCGH ED CME
 
Non-invasive ventilation - BiPAP
Non-invasive ventilation - BiPAPNon-invasive ventilation - BiPAP
Non-invasive ventilation - BiPAPmeducationdotnet
 
Approach patient with asthma. ,
Approach patient with asthma. ,Approach patient with asthma. ,
Approach patient with asthma. ,ssuserfc99be
 
Mechanical ventilation
Mechanical ventilationMechanical ventilation
Mechanical ventilationNTAPARIA
 
NAJMI OXYGEN THERAPHYy Hospital Selayang
NAJMI OXYGEN THERAPHYy Hospital SelayangNAJMI OXYGEN THERAPHYy Hospital Selayang
NAJMI OXYGEN THERAPHYy Hospital Selayangnajmishafiz
 
Chronic Obstructive Pulmonary Disease (Copd)
Chronic Obstructive Pulmonary Disease (Copd)Chronic Obstructive Pulmonary Disease (Copd)
Chronic Obstructive Pulmonary Disease (Copd)Nida Fatima
 
Emergencies Handbook.pub A4.FINAL VERSION July 2015.pdf
Emergencies Handbook.pub A4.FINAL VERSION July 2015.pdfEmergencies Handbook.pub A4.FINAL VERSION July 2015.pdf
Emergencies Handbook.pub A4.FINAL VERSION July 2015.pdfAaronNameerAbrarRahm
 
Non invasive ventilation
Non invasive ventilationNon invasive ventilation
Non invasive ventilationtbf413
 

Similar to Exacerbation of Asthma (20)

Respiratory conditions in Critically ill Surgical patient
Respiratory conditions in Critically ill Surgical patientRespiratory conditions in Critically ill Surgical patient
Respiratory conditions in Critically ill Surgical patient
 
Ventilation Strategy in obstructive Lung disease
Ventilation Strategy  in obstructive Lung diseaseVentilation Strategy  in obstructive Lung disease
Ventilation Strategy in obstructive Lung disease
 
ARDS-acute respiratory distress syndrome
ARDS-acute respiratory distress syndromeARDS-acute respiratory distress syndrome
ARDS-acute respiratory distress syndrome
 
NIV.pptx
NIV.pptxNIV.pptx
NIV.pptx
 
Chronic obstructive pulmonary disease
Chronic obstructive pulmonary diseaseChronic obstructive pulmonary disease
Chronic obstructive pulmonary disease
 
Oxygen toxicity and it’s mechanism
Oxygen toxicity and it’s mechanismOxygen toxicity and it’s mechanism
Oxygen toxicity and it’s mechanism
 
COPD with RV failure - Case Presentation
COPD with RV failure - Case PresentationCOPD with RV failure - Case Presentation
COPD with RV failure - Case Presentation
 
G M C F I N A L
G M C  F I N A LG M C  F I N A L
G M C F I N A L
 
ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASEACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
 
Approach patient with cough
Approach patient with cough Approach patient with cough
Approach patient with cough
 
NIV in Acute Exacerbation of COPD
NIV in Acute Exacerbation of COPDNIV in Acute Exacerbation of COPD
NIV in Acute Exacerbation of COPD
 
Abg skill station
Abg skill stationAbg skill station
Abg skill station
 
Non-invasive ventilation - BiPAP
Non-invasive ventilation - BiPAPNon-invasive ventilation - BiPAP
Non-invasive ventilation - BiPAP
 
Approach patient with asthma. ,
Approach patient with asthma. ,Approach patient with asthma. ,
Approach patient with asthma. ,
 
Mechanical ventilation
Mechanical ventilationMechanical ventilation
Mechanical ventilation
 
Oxygen therapy
Oxygen therapyOxygen therapy
Oxygen therapy
 
NAJMI OXYGEN THERAPHYy Hospital Selayang
NAJMI OXYGEN THERAPHYy Hospital SelayangNAJMI OXYGEN THERAPHYy Hospital Selayang
NAJMI OXYGEN THERAPHYy Hospital Selayang
 
Chronic Obstructive Pulmonary Disease (Copd)
Chronic Obstructive Pulmonary Disease (Copd)Chronic Obstructive Pulmonary Disease (Copd)
Chronic Obstructive Pulmonary Disease (Copd)
 
Emergencies Handbook.pub A4.FINAL VERSION July 2015.pdf
Emergencies Handbook.pub A4.FINAL VERSION July 2015.pdfEmergencies Handbook.pub A4.FINAL VERSION July 2015.pdf
Emergencies Handbook.pub A4.FINAL VERSION July 2015.pdf
 
Non invasive ventilation
Non invasive ventilationNon invasive ventilation
Non invasive ventilation
 

Exacerbation of Asthma

  • 1. Bryan Abadilla, SRT ACC, ONT RT-13 EXACERBATION OF ASTHMA
  • 2. • Definition: – Asthma: Respiratory disease in which the airways become inflamed causing narrowing and swelling. Also, more mucus is produced which makes breathing more difficult. – Exacerbation of asthma: An event during the natural course of asthma in which the patients baseline dyspnea, cough, and or sputum is beyond what is normal for the patient on a daily basis. • Symptoms: – SOB * – Anxiety * – Cough * – Irregular respiratory patterns * – Orthopnea – Yellow or green sputum, hemoptysis – Chest tightness * Causes: – Infection of tracheobronchial tree ( airway inflammation) – Air pollution (airway inflammation) – Exercise or stress – Smoking of any kind – 1/3 of severe exacerbations cannot be identified • Diagnosis: – 4 classes (mild, moderate, severe, life threatening) – Pulse ox on room air, <92-94 one hour after standard tx = hospitalization • Treatment: – O2 therapy; > 90% saturation – SABA + Ipratropium by nebulizer/MDI Q20 mins (or continuous neb) • Albuterol – Corticosteroid • Pulmicort • Symbicort • Prognosis: – Send pt home with systemic corticosteroids. – Allergen avoidance WHAT IS EXACERBATION OF ASTHMA? Medscape.com, aafp.org
  • 3. • 58Yr, African American Female arrives in ER via ambulance on NRB. • Chief complaint: – shortness of breath • Diagnosis: Exacerbation of asthma • Hx: – Asthma – 4 pack year smoking Hx (8 cigarettes a day X 10 yrs) – CHF – Multiple hospitalization for exacerbation of asthma – Used to work at Home Depot for 5 years – Currently unemployed PATIENT DATA
  • 4. • Shortness of breath; shallow • Anxious • Tachypnic and in severe respiratory distress • Use of accessory muscles • Breath sounds: Severe insp/exp wheezing • Vitals: – HR: 115, RR: 34, BP: 142/62, Temp: 37.9C, SpO2 90% NRB • Placed Pt. on 50% venti mask INITIAL ASSESSMENT
  • 5. • ABG on 50% Venti mask. Uncompensated Respiratory Acidosis with mild hypoxemia. – pH 7.25 – PaCO2 65 – PaO2 65 – HCO3- 25 • Critical lab findings only – Low Calcium: 1.9 mmol/L – High glucose: 133 mg/dL – High WBC: 13.5 (13,500/mcL) LAB FINDINGS
  • 6. • Doctor’s orders (pt in ER) – 50% venture mask – Titrate oxygen usage to a minimum – ABG – Labs (cbc, electorlytes, lipids) – 5mg albuterol via aerogen (ultrasonic/mesh nebulizer) • Administered x2, second dose: 5mg albuterol via aerogen 20 mins after, third dose: 2.5mg albuterol via aerogen 20 mins after second dose. – Racemic Epinephrine 2.25mg via HHN – Ativan via IV 2mg. • Allergies? • Assessment – Pt still tachypnic and wheezing after first treatment. Slight tachycardia with HR: 100-105, RR: 30-32. – 20 mins post second treatment, breath sounds improve, slight expiratory wheeze. – Ativan administered by nurse, Racemic epinephrine administered via HHN • During administration of Ativan and racemic epinephrine pt complains of itchy skin and itchy throat. • Stopped racemic epinephrine treatment. • Nurse administered Benadryl. – Patient vitals stable, breath sounds still slight wheeze, pt request to rest. Placed on 4L NC w/ bubble humidifier. Monitor patient status. DAY 1
  • 7. • Doctor’s orders – Oxygen therapy keep SpO2 >92%. – Titrate oxygen usage to minimum – Duoneb (albuterol 2.5mg/ipratropium bromide 0.5mg in 3ml solution) Q4 via UPA – Pulmicort 0.5mg BID (1mg max per day) • Assessment – Vitals stable: HR: 90, RR 18, BS: slight wheeze bilaterally, BP: 132/70, Tem p 37C. – No respiratory distress or SOB – Speaking in full sentences with no signs of distress – Semi-fowler, non-productive spontaneous cough, sputum: none. Skin is normal, warm, and dry. – Pt tolerated tx well. Post BS: unchanged, slight wheeze bilaterally. – Second Q4 tx post BS: improved, clear/diminished bilaterally. – Decreased nasal cannula from 4L to 2L. Pt. SpO2 99% on 4L. Five minutes post oxygen decrease pt SpO2 98%. Continue Q4 tx and monitor. DAY 2
  • 8. • Doctor’s orders – Oxygen therapy. Keep SpO2 >92% – Titrate oxygen usage to a minimum – Titrate down to Room air. – Duoneb (albuterol 2.5mg/ipratropium bromide 0.5mg in 3ml solution) Q4 via UPA – Pulmicort 0.5mg BID (1mg max per day) • Assessment – Reduced oxygen from 2L NC to Room air. Pt SpO2 99% on 2L. Waited 5 minutes to check Spo2 Via pulse ox. Room air SpO2 96%. – Pt looks and sounds great. Speaking in full sentences, smiling and excited to go home. – Vital signs stable – HR: 76, RR 18, BS: clear and diminished bilaterally, BP: 134/72, Temp: 37.1C – Upon next Q4 tx discovered patient has been discharged and sent home. DAY 3
  • 9. Name Class Dosage Indication Albuterol Bronchodilator 2.5mg in 3ml solution (mixed with NL saline) Bronchospasms, exacerbation of asthma. Duoneb Bronchodilator 2.5 mg albuterol/0.5 mg atrovent Bronchospasms, wheezing. Racemic Epinephrine Vasopressor 2.25%/0.5 ml Chest tightness, wheezing. Pulmicort Corticosteroids 0.5 mg BID Maintenance Tx of asthma. Ativan Benzodiazapines 2mg via IV Anti-anxiety. MEDICATION LIST www.drugs.com
  • 10. • Maintain SpO2 > 92% • Achieve patent airway and maintain airway clearance – Bronchodilator and oxygen therapy • Recommend avoiding irritants such as pollen, air pollution, cigarette smoke or any others that might trigger an asthma attack. • Send patient home with peak flow • Send patient home with prescriptions for bronchodilator therapy. • Day 1 suggestions: – Instead of trying three treatments of albuterol every 20 minutes, why not try a continuous neb treatment? And monitor patient during treatment? • Day 2&3 suggestions: – After recording breath sounds as clear/diminished, change Q4 to Q6? Or change it to Q4PRN? RECOMMENDATIONS AND PLAN OF CARE
  • 11. • Patient arrives in ED via ambulance, 4 pack year smoking hx, and hx of CHF – Respiratory distress – Tachypnic – Tachycardic – Anxious – Increased WOB – SOB – Severe insp/exp wheezing – ABG results: Uncompensated Respiratory Acidosis with mild hypoxemia • Day 1 – Placed on 50% venture mask, ABG, LABS, Albuterol, Racemic Epinephrine, and Ativan treatments. – Pt. allergic reaction to Ativan (racemic epi?) • Benadryl administered by RN – Breath sounds improved to moderate wheezing from severe, monitor patient. • Day 2/3 – Titrate oxygen use down, but keep SpO2 > 90% – Pt. now on 4/2L NC SpO2 96-98% – Duoneb and Pulmicort – Vitals stable, BS improving to mild wheezing and clear/diminished. • Sent patient home with bronchodilator treatments, and educated patient to prevent asthma attacks by avoiding irritants and other triggers. OVERALL SUMMARY AND CONCLUSION

Editor's Notes

  1. Suggest continuous nebulizer albuterol 15 mg/hr??